Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Rigel Pharmaceuticals (NQ: RIGL ) 16.04 -0.01 (-0.06%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Rigel Pharmaceuticals < Previous 1 2 3 4 5 Next > Rigel Pharma Expands Blood Cancer Portfolio With Forma Therapeutics Licensing Pact August 03, 2022 Via Benzinga Rigel Pharmaceuticals: Q2 Earnings Insights August 02, 2022 Rigel Pharmaceuticals (NASDAQ:RIGL) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Via Benzinga Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study August 02, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Earnings Outlook For Rigel Pharmaceuticals August 01, 2022 Rigel Pharmaceuticals (NASDAQ:RIGL) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that Rigel... Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session June 27, 2022 Gainers Via Benzinga Earnings Scheduled For August 2, 2022 August 02, 2022 Companies Reporting Before The Bell • Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion. Via Benzinga This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday June 28, 2022 Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade. Via Benzinga Mosaic Tumbles Around 10%, Here's 71 Biggest Movers From Yesterday June 24, 2022 Gainers Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) shares jumped 263% to $2.73 on Thursday. Blue Hat Interactive terminated its previously proposed shelf takedown... Via Benzinga 44 Stocks Moving In Thursday's Mid-Day Session: F-star Therapeutics, Revlon And More June 23, 2022 Gainers Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) rose 83.8% to $1.3824. Blue Hat Interactive terminated its previously proposed shelf takedown offering. Via Benzinga 63 Biggest Movers From Yesterday June 17, 2022 Gainers Advent Technologies Holdings, Inc. (NYSE: ADN) shares surged 244% to close at $3.99 on Thursday after the company announced it received notification of euro 782.1 million of funding from the... Via Benzinga 3 Stocks Under $1 Insiders Are Buying June 14, 2022 The Nasdaq Composite dropped by more than 500 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For June 9, 2022 June 09, 2022 Upgrades Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday June 09, 2022 Good morning! We're starting off another day of trading with an overview of the biggest pre-market stock movers for Thursday! Via InvestorPlace 18 Stocks Moving in Thursday's Pre-Market Session June 09, 2022 Gainers View, Inc. (NASDAQ: VIEW) rose 18.5% to $2.05 in pre-market trading after declining 5% on Wednesday. Via Benzinga 83 Biggest Movers From Yesterday June 09, 2022 Gainers Symbotic Inc. (NASDAQ: SYM) shares surged 120.6% to settle at $20.07 on Wednesday. Symbotic reported the completion of its business combination with SVF Investment Corp. to become a publicly... Via Benzinga Mid-Afternoon Market Update: Dow Tumbles 300 Points; HeartCore Enterprises Shares Spike Higher June 08, 2022 U.S. stocks traded lower toward the end of trading, with the Dow Jones dipping over 300 points on Wednesday. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session June 08, 2022 Via Benzinga Mid-Day Market Update: Crude Oil Rises 1%; Rigel Pharmaceuticals Shares Slide June 08, 2022 U.S. stocks traded mixed midway through trading, with the Nasdaq Composite adding around 50 points on Wednesday. Via Benzinga Why Rigel Pharmaceuticals Shares Are Falling Today June 08, 2022 Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) shares are trading lower after the company announced data from the FORWARD Phase 3 clinical trial of Fostamatinib did not demonstrate statistical significance... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For June 8, 2022 June 08, 2022 Upgrades Via Benzinga 50 Stocks Moving In Wednesday's Mid-Day Session June 08, 2022 Gainers HeartCore Enterprises, Inc. (NASDAQ: HTCR) shares gained 81% to $1.8503 after the company authorized a $3.5 million buyback. Via Benzinga Rigel Pharmaceuticals' Fostamatinib Flunks In Late-Stage Rare Blood Disorder Trial June 08, 2022 Rigel Pharmaceuticals Inc (NASDAQ: RIGL) shares are falling on disappointing data from the FORWARD Phase 3 trial of fostamatinib in patients with warm autoimmune hemolytic anemia (wAIHA). Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday June 07, 2022 Good morning! We're starting off another day of trading with a breakdown of the biggest pre-market stock movers for Tuesday! Via InvestorPlace Stocks That Hit 52-Week Lows On Wednesday June 01, 2022 On Wednesday, 73 stocks hit new 52-week lows. Via Benzinga Knight Therapeutics Secures Rights To Rigel's Fostamatinib In Latin America May 24, 2022 Knight Therapeutics Inc. (TSX: GUD) (OTC: KHTRF) Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session May 03, 2022 Gainers Via Benzinga Recap: Rigel Pharmaceuticals Q1 Earnings May 03, 2022 Rigel Pharmaceuticals (NASDAQ:RIGL) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Via Benzinga The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs May 03, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours. Via Benzinga Preview: Rigel Pharmaceuticals's Earnings May 02, 2022 Rigel Pharmaceuticals (NASDAQ:RIGL) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Rigel... Via Benzinga Earnings Scheduled For May 3, 2022 May 03, 2022 Companies Reporting Before The Bell • Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to report earnings for its first quarter. Via Benzinga < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.